News and Events

News and Events

November 2008
• Official launch of independently operating STI Pharma, LLC.

May 2008
• Acquires 3 drugs from Actavis: Triacin-C Cough Syrup, Dexamethasone Elixir, Betamethasone Valerate Lotion.

April 2007
• STI Pharma sold the US marketing rights for prescription strength Naprelan tablets to Victory Pharma. Naprelan is a leading pain product that offers the advantage of controlled release. STI retains exclusive ownership of the New Drug Application related to the Naprelan US marketing rights.

July 2006
• License to market Ethambutol Hydrochloride Oral Tablets to Heritage Pharmaceuticals Inc. Ethambutol Hydrochloride Oral Tablets are the generic for the brand Myambutol® Tablets licensed to market to X-Gen Pharmaceuticals in 2004.